Organization WH (2024) Global cancer burden growing, amidst mounting need for services. World Health Organization, Geneva, Switzerland

Google Scholar 

McNamee MJ, Michod D, Niklison-Chirou MV (2021) Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment? Cell Death Discov 7(1):87

Article  PubMed  PubMed Central  CAS  Google Scholar 

Geeraerts SL et al (2021) The ins and outs of serine and glycine metabolism in cancer. Nat Metab 3(2):131–141

Article  PubMed  CAS  Google Scholar 

Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27–47

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang M, Vousden KH (2016) Serine and one-carbon metabolism in cancer. Nat Rev Cancer 16(10):650–662

Article  PubMed  CAS  Google Scholar 

Jain M et al (2012) Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336(6084):1040–1044

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shunxi W et al (2023) Serine metabolic reprogramming in tumorigenesis, tumor immunity, and clinical treatment. Adv Nutr 14(5):1050–1066

Article  PubMed  PubMed Central  Google Scholar 

Possemato R et al (2011) Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476(7360):346–350

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang B et al (2017) PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep 19(11):2289–2303

Article  PubMed  CAS  Google Scholar 

Zhu J et al (2016) High expression of PHGDH predicts poor prognosis in non-small cell lung cancer. Transl Oncol 9(6):592–599

Article  PubMed  PubMed Central  Google Scholar 

Li AM, Ye J (2020) The PHGDH enigma: do cancer cells only need serine or also a redox modulator? Cancer Lett 476:97–105

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee CM et al (2024) PHGDH: a novel therapeutic target in cancer. Exp Mol Med 56(7):1513–1522

Article  PubMed  PubMed Central  Google Scholar 

Chen J et al (2013) Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Oncotarget 4(12):2502–2511

Article  PubMed  PubMed Central  Google Scholar 

Sha L, Wang Y, Meng P et al (2025) Pharmacological inhibition of PSPH reduces serine levels and epileptic seizures. Nat Chem Biol. https://doi.org/10.1038/s41589-025-01920-5

Pacold ME et al (2016) A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol 12(6):452–458

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen L, Liu S, Tao Y (2020) Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther 5(1):90

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wei L et al (2019) Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun 10(1):4681

Article  PubMed  PubMed Central  Google Scholar 

Reid MA et al (2018) Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism. Nat Commun 9(1):5442

Article  PubMed  PubMed Central  CAS  Google Scholar 

Maddocks OD et al (2016) Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol Cell 61(2):210–221

Article  PubMed  PubMed Central  CAS  Google Scholar 

Birsoy K, Garraway LA, Mino-Kenudson M (2012) Functional genomics reveals serine synthesis is essential in PHGDH-amplified breast cancer. Nature 476(7360):346–350

Google Scholar 

Sullivan MR et al (2019) Increased serine synthesis provides an advantage for tumors arising in tissues where serine levels are limiting. Cell Metab 29(6):1410-1421.e4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Muthusamy T et al (2020) Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature 586(7831):790–795

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cai Y et al (2023) α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis. Cell Death Discov 9(1):182

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hwang IY et al (2016) Psat1-dependent fluctuations in α-ketoglutarate affect the timing of ESC differentiation. Cell Metab 24(3):494–501

Article  PubMed  CAS  Google Scholar 

Yang L, Venneti S, Nagrath D (2017) Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng 19:163–194

Article  PubMed  CAS  Google Scholar 

Qiu Y et al (2024) The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade. Nat Metab 6(8):1529–1548

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85–95

Article  PubMed  CAS  Google Scholar 

Imai S, Guarente L (2014) NAD+ and sirtuins in aging and disease. Trends Cell Biol 24(8):464–471

Article  PubMed  PubMed Central  CAS  Google Scholar 

Furuya S (2008) An essential role for de novo biosynthesis of L-serine in CNS development. Asia Pac J Clin Nutr 17(Suppl 1):312–315

PubMed  CAS  Google Scholar 

Yoshida K et al (2004) Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality. J Biol Chem 279(5):3573–3577

Article  PubMed  CAS  Google Scholar